ATE256739T1 - Hypothalamus-spezifische polypeptide - Google Patents

Hypothalamus-spezifische polypeptide

Info

Publication number
ATE256739T1
ATE256739T1 AT97939357T AT97939357T ATE256739T1 AT E256739 T1 ATE256739 T1 AT E256739T1 AT 97939357 T AT97939357 T AT 97939357T AT 97939357 T AT97939357 T AT 97939357T AT E256739 T1 ATE256739 T1 AT E256739T1
Authority
AT
Austria
Prior art keywords
hypocretin
hypothalamus
methods
specific polypeptides
polypeptides
Prior art date
Application number
AT97939357T
Other languages
English (en)
Inventor
J Gregor Sutcliffe
Kaare M Gautvik
Lecea Luis De
Floyd E Bloom
Patria E Danielson
Vigdis T Gautvik
Thomas S Kilduff
Pamela E Foye
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21813781&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE256739(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Application granted granted Critical
Publication of ATE256739T1 publication Critical patent/ATE256739T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Child & Adolescent Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97939357T 1996-08-02 1997-08-01 Hypothalamus-spezifische polypeptide ATE256739T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2322096P 1996-08-02 1996-08-02
PCT/US1997/013657 WO1998005352A1 (en) 1996-08-02 1997-08-01 Hypothalamus-specific polypeptides

Publications (1)

Publication Number Publication Date
ATE256739T1 true ATE256739T1 (de) 2004-01-15

Family

ID=21813781

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97939357T ATE256739T1 (de) 1996-08-02 1997-08-01 Hypothalamus-spezifische polypeptide

Country Status (8)

Country Link
US (2) US6635479B1 (de)
EP (1) EP1007074B1 (de)
JP (1) JP2000516456A (de)
AT (1) ATE256739T1 (de)
AU (1) AU721644B2 (de)
CA (1) CA2261565A1 (de)
DE (1) DE69726889T2 (de)
WO (1) WO1998005352A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309854B1 (en) * 1996-12-17 2001-10-30 Smithkline Beecham Corporation Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
US6001963A (en) * 1996-12-17 1999-12-14 Smithkline Beecham Corporation Ligands of the neuropeptide receptor HFGAN72
US7973156B2 (en) 1997-08-21 2011-07-05 Quark Pharmaceuticals Inc. Hypoxia-regulated genes
EP1037655B1 (de) 1997-12-15 2004-03-03 SmithKline Beecham plc Verwendung neuer liganden des hfgan72 neuropeptiderezeptors und dessen antagonisten in der therapie
US6514719B1 (en) * 1999-05-28 2003-02-04 Immunex Corporation Methods for identifying compounds that alter kinase activity
AU6615300A (en) * 1999-07-30 2001-02-19 Board Of Trustees Of The Leland Stanford Junior University Hypocretin and hypocretin receptors in regulation of sleep and related disorders
AU2001297807A1 (en) * 2000-12-20 2002-11-11 Sri International Modulators of the hypocretin system and methods of screening therefor
US7041495B2 (en) * 2000-12-21 2006-05-09 The Trustees Of The University Of Pennsylvania Pregnancy up-regulated, nonubiquitous CaM kinase
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US20060068405A1 (en) * 2004-01-27 2006-03-30 Alex Diber Methods and systems for annotating biomolecular sequences
AU2003218321A1 (en) * 2002-03-19 2003-10-08 Incyte Corporation Kinases and phosphatases
AU2003262963A1 (en) * 2002-08-29 2004-03-19 The Regents Of The University Of California Hypocretin administration as a treatment for obesity
EP1716227A4 (de) * 2004-01-27 2010-01-06 Compugen Ltd Verfahren zur identifizierung putativer genprodukte mittels interspezies-sequenzvergleich sowie damit entdeckte biomolekulare sequenzen
EP1751111B1 (de) 2004-03-01 2014-12-31 Actelion Pharmaceuticals Ltd. Substituierte 1,2,3,4-tetrahydroisochinolinderivate
JP4675623B2 (ja) * 2004-12-28 2011-04-27 本田技研工業株式会社 燃料電池システム及びその制御方法
FR2906614B1 (fr) * 2006-10-03 2019-06-07 Serguei Fetissov Methode de diagnostic de maladies neuropsychiatriques, de troubles du comportement alimentaire ou de maladies metaboliques.
WO2009033796A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
AU2009208607B2 (en) * 2008-01-31 2013-08-01 Compugen Ltd. Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
WO2014165866A2 (en) * 2013-04-01 2014-10-09 The Board Of Trustees Of The Leland Stanford Junior University Methods for immune-based diagnosis, prevention and personalized treatment of narcolepsy
WO2023199893A1 (ja) * 2022-04-11 2023-10-19 エーザイ・アール・アンド・ディー・マネジメント株式会社 活性型オレキシンａを定量する方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128242A (en) * 1989-06-19 1992-07-07 The Administrators Of The Tulane Educational Fund Hypothalamic polypeptides with adenylate cyclase stimulating activity
US6309854B1 (en) * 1996-12-17 2001-10-30 Smithkline Beecham Corporation Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
US6001963A (en) * 1996-12-17 1999-12-14 Smithkline Beecham Corporation Ligands of the neuropeptide receptor HFGAN72
US5969123A (en) * 1998-03-06 1999-10-19 Millennium Biotherapeutics, Inc. Nucleic acid molecules derived from a brain tissue library

Also Published As

Publication number Publication date
EP1007074A1 (de) 2000-06-14
EP1007074B1 (de) 2003-12-17
US6635479B1 (en) 2003-10-21
EP1007074A4 (de) 2000-10-25
AU721644B2 (en) 2000-07-13
US20030176666A1 (en) 2003-09-18
CA2261565A1 (en) 1998-02-12
JP2000516456A (ja) 2000-12-12
AU4146497A (en) 1998-02-25
DE69726889T2 (de) 2004-10-21
DE69726889D1 (de) 2004-01-29
WO1998005352A1 (en) 1998-02-12

Similar Documents

Publication Publication Date Title
DE69726889T2 (de) Hypothalamus-spezifische polypeptide
EP1005540A4 (de) Ikk-beta proteines, nukleinsäuren und verfahren
DE69533556D1 (de) N-terminal modifizierte Polypeptide, und Herstellungsprozess
NZ279963A (en) Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946
NO851564L (no) Fremstilling av polypeptider med human-gamma-interferon-aktivitet.
Mierendorf Jr et al. Synthesis of related forms of the lysosomal enzyme alpha-mannosidase in Dictyostelium discoideum.
DE69841994D1 (de) 32 Humane sekretierte Proteine
DE59810198D1 (de) Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung
DE69533464D1 (de) Verfahren zur Herstellung von rekombinanten menschlichen LH-RH Rezeptor Proteinen in spezifischen CHO Zellinien.
EA200100264A1 (ru) Ангиоцидин: адгезионный рецептор опухолей клетки, специфический для cys-ser-val-thr-cys-gly
ATE277171T1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
ATE110742T1 (de) Peptid-verbindungen.
ATE287952T1 (de) Humanes thymosin beta 15 gen,protein und dessen verwendungen
Edwards et al. Xanthine dehydrogenase from Drosophila melanogaster: a comparison of the kinetic parameters of the pure enzyme from two wild-type isoalleles differing at a putative regulatory site
NO20000731L (no) Neisseria lactoferinbindingsprotein
BR0007816A (pt) Fator de estimulação óssea
DE69737293D1 (de) Nukleotidsequenz, die für eine flavinmonooxygenase kodiert, das korrespondierende protein, sowie deren verwendungen in diagnostik und therapie
Yaneva et al. Tissue specificity of tightly bound non-histone chromosomal proteins
ATE366810T1 (de) Menschliche p51-gene und deren genprodukte
ATE293163T1 (de) Cyclin e spezifische konstrukte und komplexe
DE60045637D1 (de) Nicotin-acetylcholin rezeptoruntereinheit, deren isolierung und verwendung
WO2001023409A8 (en) 38 human secreted proteins
EP0929310A4 (de) Diagnostische und therapeutische verfahren in zusammenhang mit der regulation der energiemobilisation durch ob-protein und ob-antikörper
HUP0002511A2 (hu) Neisseria eredetű, laktoferrinkötő fehérje
WO2000050868A3 (en) Generation of diagnostic tools to assay the human lhx3/p-lim/lim-3 factor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties